Status:

COMPLETED

Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation

Lead Sponsor:

University Hospital, Motol

Conditions:

Lung Transplantation

Eligibility:

All Genders

Brief Summary

Extracorporeal membrane oxygenation (ECMO) is a frequently used extracorporeal support measure during the intraoperative period in lung transplantation. A certain amount of anticoagulation, mainly unf...

Detailed Description

This study was designed as a single-centre, retrospective, observational study including all lung transplants between January 2020 and December 2022 within the Prague Lung Transplant Program Motol Uni...

Eligibility Criteria

Inclusion

  • \- The inclusion criteria were lung transplantation performed with intraoperative ECMO support, central ECMO cannulation, and successful ECMO support termination at the end of the surgery.

Exclusion

  • \- The exclusion criteria were lung transplant without intraoperative ECMO support, block heart-lung transplantation, ECMO bridge to lung transplant and planned postoperative ECMO.

Key Trial Info

Start Date :

January 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2023

Estimated Enrollment :

141 Patients enrolled

Trial Details

Trial ID

NCT06054997

Start Date

January 1 2020

End Date

August 1 2023

Last Update

October 3 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital in Motol

Prague, Czechia, 15006

Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation | DecenTrialz